+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

SenesTech Inc (SNES) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 55 Pages
  • October 2026
  • GlobalData
  • ID: 4398198
SenesTech Inc (SNES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

SenesTech Inc (SenesTech) develops and commercializes products for managing animal pest populations. The company's main activities involve developing and commercializing products aimed at reducing the fertility of rodents. The company’s product portfolio includes ContraPest and Evolve. ContraPest is a liquid bait containing 4-vinylcyclohexene diepoxide and triptolide, targeting the reproductive systems of male and female Norway and roof rats. It is highly palatable and does not induce illness, making it an alternative to traditional rodenticides. The company's products are used by pest control professionals and are applicable in various industries, including agriculture and public health. ContraPest is registered as a general-use pesticide and includes a hanging bait station called the Elevate Bait System. Evolve is a novel soft bait formulation that also targets the reproductive systems of male and female rats, leading to population control. SenesTech is headquartered in Phoenix, Arizona, the US.

SenesTech Inc Key Recent Developments

  • Sep 17, 2026: SenesTech To Participate in Lytham Partners Fall 2026 Investor Conference
  • Aug 31, 2026: Swampscott Municipal Integrated Pest Management Program Achieves 43% Reduction in Rodent Activity Using Evolve Rat
  • Aug 27, 2026: SenesTech Grants Inducement Equity Award Under Nasdaq Listing Rule 5635(c)(4)
  • Aug 10, 2026: SenesTech Releases Series Of Corporate Updates On Financial Results, Product Approvals, And Distribution

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • SenesTech Inc - Key Facts
  • SenesTech Inc - Key Employees
  • SenesTech Inc - Key Employee Biographies
  • SenesTech Inc - Major Products and Services
  • SenesTech Inc - History
  • SenesTech Inc - Company Statement
  • SenesTech Inc - Locations And Subsidiaries
  • Head Office
Section 2 - Company Analysis
  • Company Overview
  • SenesTech Inc - Business Description
  • R&D Overview
  • SenesTech Inc - Corporate Strategy
  • SenesTech Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • SenesTech Inc - Strengths
  • SenesTech Inc - Weaknesses
  • SenesTech Inc - Opportunities
  • SenesTech Inc - Threats
  • SenesTech Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • SenesTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • SenesTech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • SenesTech Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Sep 17, 2026: SenesTech To Participate in Lytham Partners Fall 2026 Investor Conference
  • Aug 31, 2026: Swampscott Municipal Integrated Pest Management Program Achieves 43% Reduction in Rodent Activity Using Evolve Rat
  • Aug 27, 2026: SenesTech Grants Inducement Equity Award Under Nasdaq Listing Rule 5635(c)(4)
  • Aug 10, 2026: SenesTech Releases Series Of Corporate Updates On Financial Results, Product Approvals, And Distribution
  • Aug 05, 2026: SenesTech Reports Record Q2 2026 Revenue and Gross Margin as E-Commerce Growth Accelerates
  • Aug 05, 2026: SenesTech Introduces Assessment Services to Help B2B Customers Understand Rodent Infestations
  • Aug 05, 2026: SenesTech Reports Record Q2 2026 Revenue and Gross Margin Fueled by E-Commerce Growth
  • Jun 29, 2026: SenesTech Appoints Jack Karabees as Executive Vice President of Sales
  • Jun 04, 2026: SenesTech Expands Distribution of Evolve Rodent Birth Control into Bermuda
  • May 19, 2026: SenesTech to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact Us
  • Disclaimer
List of Tables
  • SenesTech Inc, Key Facts
  • SenesTech Inc, Key Employees
  • SenesTech Inc, Key Employee Biographies
  • SenesTech Inc, Major Products and Services
  • SenesTech Inc, History
  • SenesTech Inc, Key Competitors
  • SenesTech Inc, Ratios based on current share price
  • SenesTech Inc, Annual Ratios
  • SenesTech Inc, Interim Ratios
  • SenesTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • SenesTech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2020 to YTD 2026
  • SenesTech Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • SenesTech Inc, Performance Chart (2021 - 2025)
  • SenesTech Inc, Ratio Charts
  • SenesTech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2020 to YTD 2026
  • SenesTech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2020 to YTD 2026

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Bayer AG
  • Syngenta AG
  • Rentokil Initial plc
  • Rollins Inc
  • BioLargo Inc